Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Eribulin
TPC -Vinorelbine,Gemcitabine,Docetaxel, and Pemetrexed
Locations
83
United States
Los Angeles, California, United States
Pleasant Hill, California, United States
San Diego, California, United States
Aurora, Colorado, United States
Washington D.C., District of Columbia, United States
Port Saint Lucie, Florida, United States
Start Date
December 9, 2011
Primary Completion Date
May 30, 2014
Completion Date
May 2, 2016
Last Updated
June 22, 2023
NCT06476808
NCT07361497
NCT07510724
NCT06305754
NCT05920356
NCT06128551
Lead Sponsor
Eisai Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions